ETFChannel.com
ETF Introduction: IBB — iShares Biotechnology ETF
Market News Video - Monday, April 6, 5:28 PM

Description to the Nasdaq Biotechnology Index Fund, traded under ticker symbol IBB: This ETF is a fund, created in February 2001, that corresponds to the price and yield performance, before fees and expenses, of companies primarily in the biotech sector, as represented by the NASDAQ Biotechnology Index. The underlying index includes securities of Nasdaq listed companies classified according to the Industry Classification Benchmark as either Biotech or Pharma which also meet other eligibility criteria.

Fund Name:
iShares Biotechnology ETF
Issuer:
iShares
Total Net Assets:
$10,843,441,937
Inception:
02/05/2001
Related Index:
NASDAQ Biotechnology Index (NBI)
ETF Category: 
Health
Expense Ratio: 
0.46% 
Net Asset Value: 
$165.80  
Recent NAV Premium: 
0.00% 
NAV Symbol: 
IBB.NV  
Number of Holdings: 
270  
Annualized Yield: 
0.17%  
Annualized Distribution: 
0.276  
IBB Dividend History » 
Stock Weight Amount
Moderna 8.97% $972,299,861
Amgen 7.91% $857,211,117
Gilead Sciences 6.57% $712,733,505
Illumina 5.47% $592,824,691
Regeneron Pharmaceuticals 4.47% $484,736,892
List of all 275 stocks held by IBB »
Quotes delayed 20 minutes

Buy (3.07 out of 4)
0th percentile
(ranked lower than approx. 100% of all etfs covered)
Based on data provided by Zacks Investment Research via Quandl.com
ETF Assets
IVV   $296,812,777,774
IEFA   $99,357,712,810
AGG   $89,087,691,898
IEMG   $80,078,836,166
IWF   $72,667,405,340
List of all 336 others »
Shares Short 13,860,000
Chg. from Last Month -660,000
Shares Outstanding 66,650,000
% of Shares Short 20.80%
Days to Cover 4.8
Based on third party short interest data.

IBB | iShares Biotechnology ETF | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2021, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.